Mentor Capital
Mentor Capital, Inc. is a private equity firm established in 1985, with a focus on acquisitions and investments in the medical and social use cannabis sectors. The firm provides passive equity funding and liquidity to smaller cannabis companies, ensuring that founders retain operational control while Mentor takes significant equity positions. It specializes in pre-IPO investments and prefers to engage with companies that have annual sales exceeding $40 million and are already generating earnings. Mentor Capital facilitates access to public markets for private companies, particularly in the cannabis space, where it sees opportunities for growth in medical applications such as cancer treatment and chronic pain management. The firm aims to deliver value to both its portfolio companies and its shareholders through a structured approach that also includes a planned capital raise, thereby enhancing stock value. Although originally focused on cancer-related investments, Mentor Capital is transitioning fully into the cannabis market while still retaining some previous investments. The company is headquartered in Ramona, California.
eShiksa is a developer of an education management portal that streamlines the operational processes of educational institutions. The platform features Shiksa Pay, a flexible fee management system that allows institutes to oversee various categories of fees efficiently. Students and parents can easily make online payments through their accounts or cards, providing convenience from any location. The mobile app enhances this service by enabling payments on smartphones and tablets. eShiksa's portal offers a comprehensive view of academic reports and facilitates the management, analysis, and reporting of extensive data, thereby saving time and reducing redundancy in data entry. Furthermore, it equips administrators with critical financial insights for effective planning and forecasting.
G Farma Labs supplies cannabis related products. That products include G Stik, G Drinks, Liquid Gold Vape Oil, chocolates, and cannabis pre-rolls. They also offer sprinkled with kief, and liquid goal CO2 extracted cannabis oil for the smoke.
GW Pharmaceuticals is a biopharmaceutical company based in Cambridge, United Kingdom, that specializes in the discovery, development, and commercialization of innovative therapeutics derived from its proprietary cannabinoid platform. Its primary product, Epidiolex, is an oral solution used to treat seizures associated with Lennox-Gastaut syndrome and Dravet syndrome in patients aged one year and older, and it is also under review for the treatment of tuberous sclerosis complex. In Europe, the product is marketed as Epidyolex. The company also offers Sativex, which is used for managing spasticity due to multiple sclerosis, and is advancing various cannabinoid product candidates aimed at treating conditions such as schizophrenia, autism spectrum disorder, and neonatal hypoxic ischemic encephalopathy. GW Pharmaceuticals operates primarily in Europe, the United Kingdom, and the United States, and has been established since 1998.
Bhang Inc specializes in the production and distribution of cannabis-infused products, offering a diverse portfolio that includes over 100 items such as gourmet chocolate, gum, capsules, CBD gummies, E-liquid, beet shots, tinctures, pre-rolls, sprays, and CBD crystalline isolate. The company emphasizes the use of high-quality ingredients to create premium medicated edibles. Bhang's products are available in various markets, primarily across Canada and the United States, ensuring a wide reach for its innovative offerings in the cannabis and hemp-derived cannabidiol sectors.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.